Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,764 | 16,811 | 13,141 | 2,225 | 12,329 |
| Marketable Securities | 32,572 | 33,814 | 21,048 | N/A | N/A |
| Receivables | 1,207 | 271 | 341 | 2,551 | 1,090 |
| Other current assets | 1,961 | 2,462 | 1,301 | 1,106 | 992 |
| TOTAL | $85,765 | $65,995 | $39,857 | $5,882 | $16,301 |
| Non-Current Assets | |||||
| PPE Net | 15,165 | 6,048 | 9,955 | 15,142 | 18,988 |
| Intangibles | 4,671 | 4,671 | 4,671 | 0 | 0 |
| Other Non-Current Assets | 2,445 | 2,550 | 3,326 | 6,048 | 4,615 |
| TOTAL | $22,281 | $13,269 | $17,952 | $21,190 | $23,603 |
| Total Assets | $108,046 | $79,264 | $57,809 | $27,072 | $39,904 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,290 | 3,443 | 2,750 | 10,000 | N/A |
| Accounts payable and accrued liabilities | 4,919 | 3,107 | 2,110 | 2,235 | 3,210 |
| Accrued Expenses | 9,846 | 4,609 | 2,419 | 5,319 | 5,289 |
| Other current liabilities | 2,942 | 350 | 218 | 877 | 1,703 |
| TOTAL | $36,183 | $20,734 | $14,085 | $26,610 | $18,018 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,784 | 10,949 | 14,392 | 4,000 | 4,000 |
| Deferred Revenues | 10,186 | 8,259 | 4,597 | 4,363 | 5,310 |
| Other Non-Current Liabilities | 359 | 0 | 5,552 | 0 | 237 |
| TOTAL | $15,099 | $12,941 | $21,023 | $5,026 | $6,465 |
| Total Liabilities | $51,282 | $33,675 | $35,108 | $31,636 | $24,483 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,657 | 42,004 | 26,020 | 62,981 | 19,371 |
| Common Shares | 44 | 32 | 26 | 8 | 19 |
| Retained earnings | -327,659 | -256,048 | -203,559 | -153,372 | -108,394 |
| Other shareholders' equity | -250 | -206 | -45 | -6 | -53 |
| TOTAL | $56,764 | $45,589 | $22,701 | $-4,564 | $15,421 |
| Total Liabilities And Equity | $108,046 | $79,264 | $57,809 | $27,072 | $39,904 |